Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Biomol Screen ; 17(7): 868-76, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22573733

ABSTRACT

CEfrag is a new fragment screening technology based on affinity capillary electrophoresis (ACE). Here we report on the development of a mobility shift competition assay using full-length human heat shock protein 90α (Hsp90α), radicicol as the competitor probe ligand, and successful screening of the Selcia fragment library. The CEfrag assay was able to detect weaker affinity (IC(50) >500 µM) fragments than were detected by a fluorescence polarization competition assay using FITC-labeled geldanamycin. The binding site of selected fragments was determined by co-crystallization with recombinant Hsp90α N-terminal domain and X-ray analysis. The results of this study confirm that CEfrag is a sensitive microscale technique enabling detection of fragments binding to the biological target in near-physiological solution.


Subject(s)
Adenosine Triphosphatases/antagonists & inhibitors , Drug Discovery , Electrophoresis, Capillary , Electrophoretic Mobility Shift Assay , HSP90 Heat-Shock Proteins/antagonists & inhibitors , HSP90 Heat-Shock Proteins/metabolism , Macrolides/metabolism , Adenosine Triphosphatases/chemistry , Adenosine Triphosphatases/metabolism , Adenosine Triphosphate/metabolism , Binding Sites , Crystallography, X-Ray , Drug Evaluation, Preclinical , HSP90 Heat-Shock Proteins/chemistry , Humans , Protein Binding , Protein Structure, Tertiary , Small Molecule Libraries
SELECTION OF CITATIONS
SEARCH DETAIL